Home > H3D News > News

News

Current news articles are found here.

GOLD MEDALLIST CHIBALE WARNS OF AFRICAN 'BRAIN DRAIN'
Wed, 24 Oct 2018 - 14:00

UCT’S H3D DIRECTOR, KELLY CHIBALE, WINS SACI GOLD MEDAL AWARD AND IS HONOURED BY ASTMH; WARNS ABOUT THE BRAIN DRAIN OF AFRICAN SCIENTISTS

Professor Kelly Chibale, founder and director of the Drug Discovery and Development Centre, H3D, at the University of Cape Town (UCT), has been awarded the prestigious Gold Medal for 2018 by the South African Chemical Institute (SACI) and honoured by the American Society of Tropical Medicine and Hygiene (ASTMH) with the 2018 Commemorative Fund Lecture.  

GRAND CHALLENGES MEETING
Wed, 24 Oct 2018 - 14:00

Prof Kelly Chibale participated in the Bill and Melinda Gates Foundation's Grand Challenges meeting held in Berlin, Germany from 15-18 October 2018 and gave a Spotlight talk.  

PRACTICAL ASPECTS OF DRUG DISCOVERY
Fri, 29 Jun 2018 - 14:00
Learn about the theoretical, practical and organisational aspects of small molecule and natural product drug discovery.
UCT KEY IN NEW DRUGS SEARCH
Fri, 29 Jun 2018 - 14:00
The University of Cape Town’s Drug Discovery and Development Centre (H3D) will be pivotal in a new international drug discovery programme aimed at financing not only the identification of new drug candidates to combat diseases such as malaria and tuberculosis, but also the development of African scientists.
OPEN CALL FOR LETTER OF INTENT (LOI) ON DRUG DISCOVERY
Mon, 23 Apr 2018 - 14:00
1. Background

Drug discovery excellence is a critical prerequisite for success in drug development and remains a highly neglected area for the African continent. The lack of market incentives has biased drug discovery efforts globally away from diseases most prevalent in the developing world. Collaborative efforts of multidisciplinary teams – in drug discovery and other fields – shows that success and efficiency increases significantly when individual contributors combine their complementary capabilities. The whole is greater than the sum of its parts. State-of-the-art approaches to implementing drug discovery projects, especially when the goal is to also build drug discovery capability on the African continent, need to be supported.

PIONEER OF WORLD CLASS DRUG DISCOVERY CENTRE IN AFRICA IS NAMED ONE OF FORTUNE’S 50 WORLD’S GREATEST LEADERS FOR 2018
Mon, 23 Apr 2018 - 14:00

The founder and director of Africa’s first integrated drug discovery centre, Professor Kelly Chibale, has been named as one of Fortune magazine’s World’s Greatest Leaders for 2018.

Chibale, whose H3D centre at the University of Cape Town pioneers world-class drug discovery in Africa, has also become known for his pivotal work on malaria.

THE WORLD'S 50 GREATEST LEADERS
Thu, 19 Apr 2018 - 18:00

45. Kelly Chibale

Scientist, South Africa

In much of Africa, the infrastructure to support scientific research is sorely lacking. But Chibale is working to change that. The Zambian chemist has built H3D, Africa’s first integrated drug discovery center, at the University of Cape Town. His team now includes more than 90 researchers; they work out of state-of-the-art facilities thanks to partnerships with the Gates Foundation, Novartis, and South Africa’s government. H3D already has a potential drug for ­malaria in human trials.

Project team
MERCK, UNIVERSITY OF CAPE TOWN AND MEDICINES FOR MALARIA VENTURE JOIN FORCES TO FEED THE ANTIMALARIAL PIPELINE
Thu, 19 Apr 2018 - 15:00
Merck, the University of Cape Town and Medicines for Malaria Venture create an antimalarial drug discovery platform, strengthening their partnership in the fight against malaria The partners will collaborate to build research capacity in Africa
EXPRESSO INTERVIEW
Wed, 21 Feb 2018 - 18:00

Expresso Show

We chat with Professor Kelly Chibale from the South African Medical Research Council to get an update on Malaria and which hotspots to watch out for over the festive season.

 

ANOTHER WIN FOR H3D AS KELLY CHIBALE ACHIEVES A-RATING
Wed, 20 Dec 2017 - 18:00

Having grown up in the villages and townships of Zambia, Professor Kelly Chibale became well acquainted with the ravages of malaria at a young age. Now, inspired by a deep spirituality and a love of chemistry, his invaluable contribution to the ongoing battle against this disease – among others – has been awarded an A rating by the National Research Foundation.

 

19th RSC/ SCI MEDICINAL CHEMISTRY SYMPOSIUM
Fri, 06 Oct 2017 - 18:00

MedChemNet and Infectious Diseases Hub were absolutely delighted to attend the first two days of the recent 19th RSC / SCI Medicinal Chemistry Symposium – Europe’s premier biennial Medicinal Chemistry event – focusing on first disclosures of significant new therapeutic agents across all disease areas and new strategies in medicinal chemistry.

FIGHTING MALARIA IN THE LAB
Fri, 06 Oct 2017 - 18:00

Kelly Chibale, Professor of Organic Chemistry at Cape Town University in South Africa, talks about his drug discovery work and coming up with compounds that might have an impact on malaria control and elimination

YouTube Link

Pages